Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04206644
Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages
Sponsor: Rennes University Hospital
View on ClinicalTrials.gov
Summary
The Sclero-JAK project aims to assess the impact of a JAK1/2 inhibitor (ruxolitinib) on activation states of monocytes-derived macrophages (MDM) from systemic sclerosis (SSc) patients
Key Details
Gender
All
Age Range
18 Years - 18 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2021-01-21
Completion Date
2027-02-13
Last Updated
2023-04-12
Healthy Volunteers
Not specified
Conditions
Interventions
OTHER
biological analysis
biological analysis of the Concentration of CCL18
Locations (1)
Rennes University Hospital
Rennes, France